Inflammatory bowel disease : How effective is TNF-α suppression?
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Related Research Unit(s)
Detail(s)
Original language | English |
---|---|
Article number | e0165782 |
Journal / Publication | PLoS ONE |
Volume | 11 |
Issue number | 11 |
Publication status | Published - 1 Nov 2016 |
Link(s)
DOI | DOI |
---|---|
Attachment(s) | Documents
Publisher's Copyright Statement
|
Link to Scopus | https://www.scopus.com/record/display.uri?eid=2-s2.0-84994796464&origin=recordpage |
Permanent Link | https://scholars.cityu.edu.hk/en/publications/publication(38741904-e1c7-4669-ad11-074b9bea45ff).html |
Abstract
Crohn's Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-α blockage benefits the group with Th1High/Th2Low while, by contrast, the group with Th1Low/Th2High will benefit from immune activation.
Research Area(s)
Citation Format(s)
Inflammatory bowel disease: How effective is TNF-α suppression? / Lo, Wing-Cheong; Arsenescu, Violeta; Arsenescu, Razvan I. et al.
In: PLoS ONE, Vol. 11, No. 11, e0165782, 01.11.2016.
In: PLoS ONE, Vol. 11, No. 11, e0165782, 01.11.2016.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Download Statistics
No data available